Sage Therapeutics Inc (SAGE)
14.72
+0.72
(+5.14%)
USD |
NASDAQ |
Apr 25, 10:39
Sage Therapeutics Price: 14.72 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 24, 2024 | 13.85 | 14.52 | 13.45 | 14.00 | 2.334M |
Apr 23, 2024 | 12.91 | 13.38 | 12.74 | 12.95 | 815185.0 |
Apr 22, 2024 | 13.42 | 13.50 | 12.89 | 12.89 | 803340.0 |
Apr 19, 2024 | 12.93 | 13.61 | 12.93 | 13.33 | 1.259M |
Apr 18, 2024 | 12.24 | 13.50 | 12.20 | 13.04 | 1.758M |
Apr 17, 2024 | 12.96 | 13.42 | 10.92 | 12.57 | 4.316M |
Apr 16, 2024 | 15.22 | 15.74 | 15.06 | 15.63 | 1.939M |
Apr 15, 2024 | 15.60 | 15.60 | 15.06 | 15.32 | 846150.0 |
Apr 12, 2024 | 16.27 | 16.37 | 15.28 | 15.44 | 1.429M |
Apr 11, 2024 | 16.66 | 16.81 | 16.24 | 16.57 | 732526.0 |
Apr 10, 2024 | 16.26 | 16.56 | 15.88 | 16.45 | 843510.0 |
Apr 09, 2024 | 16.68 | 17.04 | 16.27 | 16.52 | 648454.0 |
Apr 08, 2024 | 16.48 | 16.76 | 16.28 | 16.60 | 495020.0 |
Apr 05, 2024 | 16.47 | 16.76 | 16.00 | 16.42 | 669655.0 |
Apr 04, 2024 | 17.05 | 17.50 | 16.48 | 16.58 | 794550.0 |
Apr 03, 2024 | 17.20 | 17.45 | 16.75 | 17.15 | 799796.0 |
Apr 02, 2024 | 17.67 | 17.79 | 17.24 | 17.25 | 771345.0 |
Apr 01, 2024 | 18.71 | 18.76 | 17.80 | 17.90 | 667781.0 |
Mar 28, 2024 | 19.06 | 19.34 | 18.51 | 18.74 | 1.005M |
Mar 27, 2024 | 18.80 | 19.19 | 18.71 | 19.04 | 551465.0 |
Mar 26, 2024 | 19.25 | 19.25 | 18.42 | 18.62 | 830173.0 |
Mar 25, 2024 | 19.16 | 19.52 | 18.60 | 18.69 | 530933.0 |
Mar 22, 2024 | 20.23 | 20.32 | 19.18 | 19.22 | 447310.0 |
Mar 21, 2024 | 19.78 | 20.28 | 19.26 | 19.97 | 791236.0 |
Mar 20, 2024 | 19.09 | 19.74 | 18.86 | 19.68 | 681438.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
12.57
Minimum
Apr 17 2024
189.96
Maximum
Jul 12 2019
59.70
Average
43.58
Median
Price Benchmarks
Biogen Inc | 199.68 |
Perspective Therapeutics Inc | 1.63 |
Vanda Pharmaceuticals Inc | 4.535 |
ADMA Biologics Inc | 6.355 |
Finch Therapeutics Group Inc | 2.17 |
Price Related Metrics
PS Ratio | 10.19 |
PEG Ratio | -2.087 |
Price to Book Value | 1.107 |
Earnings Yield | -61.48% |
Market Cap | 884.77M |
PEGY Ratio | -2.087 |